Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2340274A H1N1 Vaccine in Adults 18-64 Years
NCT01008956Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Apr 2010
- Primary completion
- Oct 2010
- Modality
- Whole Inactivated Vaccines
01
Overview
A Phase 2 trial of influenza vaccine (split virion, inactivated, H1N1) in Influenza A H1N1 (H1N1), sponsored by GSK. Planned start Apr 2010; status: withdrawn.
02
Drugs
influenza vaccine (split virion, inactivated, H1N1)
03
Conditions
Influenza A H1N1 (H1N1)
Beyond the preview
Go deeper on NCT01008956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008956.